Testosterone therapy among older men showed promising results in reducing risk of heart attacks and strokes, a new study shows.
A group of researchers from the Intermountain Medical Centre Heart Institute in Salt Lake City, U.S. claim in a recent study that older men aged 58-78 who take hormone replacement therapy (HRT) are less likely to experience heart attack or stroke by as much as 80 percent.
The study, which followed 755 adult men, debunks a recently held belief that hormonal therapy, especially testosterone replacement, increases the risk of cardiovascular diseases. The study participants have low levels of testosterone and coronary artery disease.
Dr. Brent Muhlestein, who led the research team, told the Daily Mail that the effects of TRT, which brings men’s testosterone level to normal, does not cause nor increase risk of cardiovascular disease. In fact, it’s the complete opposite, as what was previously thought.
“The study shows that using testosterone replacement therapy to increase testosterone to normal levels in androgen-deficient men doesn’t increase their risk of a serious heart attack or strokes. That was the case even in the highest-risk men – those with known pre-existing heart disease,” Muhlestein was quoted as saying by the Daily Mail.
According to the U.S. National Library of Medicine National Institute of Health, HRT is the most common therapy of choice for men experiencing hypogonadism. Among the most common symptoms of the condition are the decreased level of libido, reduced muscle mass, osteoporosis, and even depression, among others.
The condition is mostly common among older men, with a prevalence rate of 20-40 percent in the U.S. Apart from the aforementioned symptoms, significantly lowered level of testosterone in the blood is one of the major indicators of the disease.